Guangdong, China

Hu Chen

This inventor holds 3 USPTO granted patents. Top assignees: Sino-Swed Tongkang Bio-Tech (Shenzhen) Limited, Baby Trend Inc., Dongguan Jinwang Children Products Co Ltd.. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hu Chen. Retrieved from https://idiyas.com/inventor/hu-chen-4dho2005

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.4

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Hu Chen: Pioneering Advances in Antibody Development

Introduction

Hu Chen, an innovative inventor based in Guangdong, China, has made significant contributions to the field of biotechnology with a focus on antibody development. With a total of three patents to his name, he is recognized for his work in creating advanced recombinant chicken IgY antibodies, which hold promise for various medical applications.

Latest Patents

Chen's latest patents include groundbreaking advancements such as the development of recombinant chicken IgY monoclonal antibodies and scFv antibodies raised against human thymidine kinase 1 expressed in mammalian cells. He disclosed a preparation method and highlighted the use of these antibodies, characterized by their unique amino acid sequences. Another noteworthy patent focuses on the expression of these antibodies in prokaryotic cells, demonstrating high immunoreactivity, specificity, and sensitivity, while also being easier to separate and purify.

Career Highlights

Throughout his career, Hu Chen has collaborated with notable companies, including Sino-Swed Tongkang Biotech (Shenzhen) Limited and Dongguan Jinwang Children Products Co., Ltd. His work has contributed to the development of innovative solutions in the biotechnology sector, particularly in antibody research and applications.

Collaborations

Working alongside talented colleagues such as Zuosheng Li and Huijun Li, Chen has fostered a collaborative environment that promotes the sharing of ideas and expertise in the field. These partnerships have allowed for the successful advancement of his patent developments and research initiatives.

Conclusion

Hu Chen stands out as a significant figure in the biotechnology space, particularly in the development of antibody technologies. His patents showcase a commitment to innovation and research that could lead to new therapeutic solutions, benefiting the medical community and beyond. As he continues his work, the impact of his inventions is expected to grow, further solidifying his legacy in the world of science and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…